Nilüfer KOÇAK, Banu LEBE, Özlem BARUT SELVER, Mehmet Özgür ZENGİN, Süleyman KAYNAK

Histological changes in the healing process of sclerotomy sites after 20-gauge and transconjunctival 23- and 25-gauge incisions in experimental model*

To evaluate the healing mechanism and histological changes of the 20-gauge standard, and 23- and 25-gauge transconjunctival sutureless vitrectomy (TSV) incisions in rabbits. Materials and methods: Twelve of 16 albino rabbits’ right eyes underwent sclerotomy of either 20-gauge standard, or 23-gauge or 25-gauge TSV incisions. Four rabbits were tested as controls. The study eyes were examined clinically on the first postoperative day and in 3-day periods for 2 weeks. After 2 weeks, rabbits were euthanized; globes were enucleated and underwent histological examination. The sclerotomy sites were investigated histopathologically under light microscope for wound healing semicantitatively. Results: Pathological sections were examined to monitor the healing course of the sclerotomy sites. Edema, mononuclear inflammatory cell infiltration, fibroplasia, foreign body reaction, neovascularization, and reactive-regenerative changes on ciliary body were evaluated and scored. Fibroplasia and reactive-regenerative changes on ciliary body were statistically significant in eyes treated with 20-gauge standard sclerotomy (P < 0.05). For foreign body reaction results, there was no statistically significant difference between all groups (P > 0.05). Conclusion: Conventional 20-gauge sclerotomies required conjunctival peritomy and suturing. Transconjunctival 23-gauge and 25-gauge sclerotomy incision procedures without sutures and peritomy decrease overall surgical time, avoid the local inflammatory reaction to the suture materials, decrease postoperative inflammation, and support rapid healing recovery.

Anahtar Kelimeler:

Key words: Sclerotomy, transconjunctival sutureless vitrectomy incision, wound healing

Histological changes in the healing process of sclerotomy sites after 20-gauge and transconjunctival 23- and 25-gauge incisions in experimental model*

Keywords:

Key words: Sclerotomy, transconjunctival sutureless vitrectomy incision, wound healing,

PDF

___

1. Keshavamurthy R, Venkatesh P, Garg S. Ultrasound biomicroscopy fi ndings of 25 G transconjuctival sutureless (TSV) and conventional (20G) pars plana sclerotomy in the same patient. BMC Ophthalmol 2006; 28: 7.
2. Kwok AK, Th am CC, Lam DS, Li M, Chen JC. Modifi ed sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol 1999; 127: 731-3.
3. Singh RP, Bando H, Brasil OFM, Williams DR, Kaiser PK. Evaluation of wound closure using diff erent incision techniques with 23-gauge and 25-gauge microincision vitrectomy systems. Retina 2008; 28: 242-8.
4. Chen JC. Sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol 1996; 114: 1273-5.
5. Jackson T. Modifi ed sutureless sclerotomies in pars plana vitrectomy [letter]. Am J Ophthalmol 2000; 129: 116-7.
6. Fujii GY, De Juan E Jr, Humayun MS, Chang TS, Pieramici DJ, Barnes A et al. Initial experience using the transconjunctival sutureless vitrectomy system for vitreoretinal surgery. Ophthalmology 2002; 109: 1814-20.
7. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina 2005; 25: 208-11.
8. Kunimoto DY, Kaiser RS; Wills Eye Retina Service. Incidence of endophthalmitis aft er 20- and 25-gauge vitrectomy. Ophthalmology 2007; 114: 2133-7.
9. Lewis H. Sutureless microincision vitrectomy surgery: unclear benefi t, uncertain safety. Am J Ophthalmol 2007; 144: 613-5.
10. Singh A, Stewart JM. 25-gauge sutureless vitrectomy variations in incision architecture. Retina 2009; 29: 451-5.
11. Kellner L, Wimpissinger B, Stolba U, Brannath W, Binder S. 25-gauge vs 20-gauge system for pars plana vitrectomy: a prospective randomised clinical trial. Br J Ophthalmol 2007; 91: 945-8.
12. Ibarra MS, Hermel M, Prenner JL, Hassan TS. Longer-term outcomes of transconjunctival sutureless 25-gauge vitrectomy. Am J Ophthalmol 2005; 139: 831-6.
13. Nagpal M, Wartikar S, Nagpal K. Comparison of clinical outcomes and wound dynamics of sclerotomy ports of 20, 25, and 23 gauge vitrectomy. Retina 2009; 29: 225-31.
14. Lakhanpal RR, Humayun MS, de Juan E, Jr, Lim JI, Chong LP, Chang TS et al. Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology 2005; 112: 817-24.
15. Singh A, Chen JA, Stewart JM. Ocular surface fl uid contamination of sutureless 25-gauge vitrectomy incisions. Retina 2008; 28: 553-7.
16. Taban M, Ventura AA, Sharma S, Kaiser PK. Dynamic evaluation of sutureless vitrectomy wounds: an optical coherence tomography and histopathology study. Ophthalmology 2008; 115: 2221-28.
17. Taban M, Sharma S, Ventura AA, Kaiser PK. Evaluation of wound closure in oblique 23-gauge sutureless sclerotomies with visante optical coherence tomography. Am J Ophthalmol 2009; 147: 101-7.
18. López-Guajardo L, Pareja-Esteban J, Teus-Guezala MA. Oblique sclerotomy technique for prevention of incompetent wound closure in transconjunctival 25-gauge vitrectomy. Am J Ophthalmol 2006; 141: 1154-6.
19. Inoue M, Shinoda K, Shinoda H, Kawamura R, Suzuki K, Ishida S. Two-step oblique incision during 25-gauge vitrectomy reduces incidence of postoperative hypotony. Clin Experiment Ophthalmol 2007; 35: 693-6.
20. Eckardt C. Transconjunctival sutureless 23-gauge vitrectomy. Retina 2005; 25: 208-11.
21. Shimada H, Nakashizuka H, Mori R, Mizutani Y, Hattori T. 25-gauge scleral tunnel transconjunctival vitrectomy. Am J Ophthalmol 2006; 142: 871-73.
22. Wan T, Hu J, Luo Y, Xu Z, Lin S, Ma P et al. Experimental study of the healing condition of sclerotomy sites aft er 25-gauge transconjunctival sutureless sclerotomy and 20-gauge vitrectomy. Yan Ke Xue Bao 2007; 23: 37-42.
23. Chen E. 25-Gauge transconjunctival sutureless vitrectomy. Curr Opin Ophthalmol. 2007; 18: 188-93.